Executive function, more than global cognition, predicts functional decline and mortality in elderly women
- PMID: 17921427
- PMCID: PMC2049089
- DOI: 10.1093/gerona/62.10.1134
Executive function, more than global cognition, predicts functional decline and mortality in elderly women
Abstract
Background: Functional impairment in community-dwelling older adults is common and is associated with poor outcomes. Our goal was to compare the contribution of impairment in executive function or global cognitive function to predicting functional decline and mortality.
Methods: We studied 7717 elderly women enrolled in a prospective study (mean age 73.3 years) and identified women with poor baseline executive function (score > 1 standard deviation [SD] below the mean on the Trail Making Test B (Trails B; n = 957, 12.4%), poor global cognitive function (score > 1 SD below the mean on a modified Mini-Mental State Examination [mMMSE], n = 387, 5.0%), impairment in both (n = 249, 3.2%), or no impairment (n = 6124, 79.4%). We compared level of functional difficulty (Activities of Daily Living [ADLs] and Instrumental ADLs [IADLs]) at baseline and at 6-year follow-up and survival at follow-up. We also determined if the association was independent of age, education, depression, medical comorbidities, and baseline functional ability.
Results: At baseline, women with Trails B impairment only or impairment on both tests reported the highest proportion of ADL and IADL dependence compared to the other groups. At the 6-year follow-up after adjusting for age, education, medical comorbidities, depression, and baseline ADL or IADL, women with only Trails B impairment were 1.3 times more likely to develop an incident ADL dependence (adjusted odds ratio [OR] = 1.34; 95% confidence interval [CI], 1.07-1.69) and 1.5 times more likely to develop a worsening of ADL dependence (adjusted OR = 1.48; 95% CI, 1.16-1.89) when compared to women with no impairment on either test. In addition, women with only Trails B impairment had a 1.5-fold increased risk of mortality (adjusted hazard ratio [HR] = 1.48; 95% CI, 1.21-1.81). In contrast, women with impairment on only mMMSE were not at increased risk to develop incident ADL or IADL dependence, a worsening of ADL or IADL dependence, or mortality.
Conclusion: Compared to women with no impairment, women with executive function impairment had significantly worse ADL and IADL function cross-sectionally and over 6 years. Individuals with executive dysfunction also had increased risk of mortality. These results suggest that screening of executive function can help to identify women who are at risk for functional decline and decreased survival.
References
-
- Broe GA, Jorm AF, Creasey H, et al. Impact of chronic systemic and neurological disorders on disability, depression and life satisfaction. Int J Geriatr Psychiatry. 1998;13:667–673. - PubMed
-
- Fried LP, Guralnik JM. Disability in older adults: evidence regarding significance, etiology, and risk. J Am Geriatr Soc. 1997;45:92–100. - PubMed
-
- Fried LP, Kronmal RA, Newman AB, et al. Risk factors for 5-year mortality in older adults: the Cardiovascular Health Study. JAMA. 1998;279:585–592. - PubMed
-
- Scott WK, Macera CA, Cornman CB, Sharpe PA. Functional health status as a predictor of mortality in men and women over 65. J Clin Epidemiol. 1997;50:291–296. - PubMed
-
- Stuck AE, Walthert JM, Nikolaus T, Bula CJ, Hohmann C, Beck JC. Risk factors for functional status decline in community-living elderly people: a systematic literature review. Soc Sci Med. 1999;48:445–469. - PubMed
Publication types
MeSH terms
Grants and funding
- AG05407/AG/NIA NIH HHS/United States
- AG05394/AG/NIA NIH HHS/United States
- R01 AG005407/AG/NIA NIH HHS/United States
- R01 AG022538/AG/NIA NIH HHS/United States
- AR35583/AR/NIAMS NIH HHS/United States
- R01 AG026720-01/AG/NIA NIH HHS/United States
- L30 AG024692/AG/NIA NIH HHS/United States
- R01-AG22538/AG/NIA NIH HHS/United States
- R01 AR035582/AR/NIAMS NIH HHS/United States
- R01 AG005394/AG/NIA NIH HHS/United States
- AR35584/AR/NIAMS NIH HHS/United States
- R01 AG021918/AG/NIA NIH HHS/United States
- R01 AR035583/AR/NIAMS NIH HHS/United States
- AR35582/AR/NIAMS NIH HHS/United States
- R01 AG026720/AG/NIA NIH HHS/United States
- R01 AR035584/AR/NIAMS NIH HHS/United States
- R01 AG021918-01/AG/NIA NIH HHS/United States